Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Aguora Hills, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncotelic Therapeutics, Inc. has filed 1,204 SEC EDGAR filings since 04 Apr 1996

SEC filing history

Showing 276-300 of 770 matching filings.

Per page
25
Current page
12
3

3 filing

Filing date
02 May 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 May 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-45691

SCHEDULE 13D

Filing date
02 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-45691

SCHEDULE 13D

Filing date
02 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-45691

SCHEDULE 13D

Filing date
02 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-45691

SCHEDULE 13D

Filing date
02 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
30 Apr 2019
Reporting date
30 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
25 Apr 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
18 Apr 2019
Reporting date
17 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

8-K

Filing date
16 Apr 2019
Reporting date
10 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-21990

NT 10-K

Filing date
02 Apr 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45691

SABBY 13G MATN 1.02.19

Filing date
02 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-226832

S-8

Filing date
14 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-225600

424B5

Filing date
27 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-225600

EFFECT filing

Filing date
26 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Jun 2018
Reporting date
20 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .